Screener
NewAmsterdam Pharma Company NAMS Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by NewAmsterdam Pharma Company in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: NewAmsterdam Pharma Company’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333824
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Property, plant and equipment, net | 411 | 383 |
| Operating right of use asset | 82 | 185 |
| Intangible assets | 343 | 407 |
| Total assets | 704,452 | 769,284 |
| Liabilities and Shareholders' Equity | ||
| Current liabilities: | ||
| Accounts payable | 5,422 | 8,970 |
| Accrued expenses and other current liabilities | 10,277 | 15,422 |
Item 1. Financial Statements.
FAQ
- What is NewAmsterdam Pharma Company's total assets?
- NewAmsterdam Pharma Company (NAMS) reported total assets of $704.45M in Q2 2026.
- How has NewAmsterdam Pharma Company's total assets changed year-over-year?
- NewAmsterdam Pharma Company's total assets decreased by 13.6% year-over-year, from $815.11M to $704.45M.
- What is the long-term trend for NewAmsterdam Pharma Company's total assets?
- Over 3 years (2022 to 2025), NewAmsterdam Pharma Company's total assets has grown at a 17.1% compound annual growth rate (CAGR), from $478.5M to $769.28M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about NewAmsterdam Pharma Company's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude